U.S. drugmaker says lab studies “reinforce our confidence” that vaccine will protect against new variants, but they’re trialling 3rd dose on South Africa strain. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.